The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFerro-alloy Re. Regulatory News (FAR)

Share Price Information for Ferro-alloy Re. (FAR)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 4.95
Bid: 4.70
Ask: 5.20
Change: 0.00 (0.00%)
Spread: 0.50 (10.638%)
Open: 4.75
High: 4.95
Low: 4.75
Prev. Close: 4.95
FAR Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Grant of Options

22 Sep 2022 07:00

RNS Number : 2174A
Ferro-Alloy Resources Limited
22 September 2022
 

This announcement contains inside information for the purposes of Article 7 of Regulation (EU) No 596/2014 which is part of UK law by virtue of the European Union (Withdrawal) Act 2018.

 

22 September 2022

Ferro-Alloy Resources Limited ('FAR' or the 'Company' or the 'Group')

Grant of Options

Ferro-Alloy Resources Limited (LSE:FAR), the vanadium producer and developer of the large Balasausqandiq vanadium deposit in Southern Kazakhstan, today announces that is has granted options over 250,000 ordinary shares in the Company ('Options') under the Company's share option scheme to Andrey Andreyovich Kuznetsov, Commercial Director of the Company's operating subsidiary, TOO Firma Balausa and part of the Group's senior management team.

The Options are exercisable on the third anniversary from the date of grant ('Exercise Date') and are exercisable for a period of two years commencing on the Exercise Date. The Options have an exercise price of 12.22p pence being the closing mid-market price of the Company's ordinary shares as quoted on the main market of the London Stock Exchange on the last business day before the date of grant.

 

Name

Options Granted

Exercise Price

Exercise Date

Total options held post grant

 

Andrey Andreyovich Kuznetsov

 

 

250,000

 

12.22p

 

22 September 2025

 

250,000

 

 

**ENDS**

 

For further information, visit   www.ferro-alloy.com  or   contact:

Ferro-Alloy Resources Limited

Nick Bridgen (CEO)

info@ferro-alloy.com

 

Shore Capital

(Joint Corporate Broker)

Toby Gibbs/John More 

+44 207 408 4090

Liberum Capital Limited

(Joint Corporate Broker)

Scott Mathieson/William King

 

+44 20 3100 2000

St Brides Partners Limited

(Financial PR & IR Adviser)

Catherine Leftley/Ana Ribeiro

+44 207 236 1177

 

The notification below is made in accordance with the requirements of article 19 of MAR and provides further details, including as to awards granted to persons discharging managerial responsibility, which has been updated accordingly.

 

1.

Details of the person discharging managerial responsibilities / person closely associated

a.

Name

Andrey Andreyovich Kuznetsov

2.

Reason for the notification

a.

Position/status

Senior management team

b.

Initial notification/Amendment

Initial Notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a.

Name

Ferro-Alloy Resources Limited

b.

LEI

2138003T5CF6U9W7Z780

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a.

Description of the Financial instrument, type of instrument Identification code

Ordinary Shares NPV

GG00BGDYDZ69

b.

Nature of the transaction

Grant of Share Options

c.

Price(s) and volume(s)

 

Price

Volume

12.22p

 

250,000

 

 

d.

Aggregated information

- Aggregated volume

- Price

 

250,000

12.22 pence

e.

Date of the transactions

22 September 2022

f.

Place of the transactions

London Stock Exchange

 

About Ferro-Alloy Resources Limited:

The Company's operations are all located at the Balasausqandiq deposit in Kyzylordinskoye Oblast in the South of Kazakhstan. Currently the Company has two main business activities:

a) the high grade Balasausqandiq vanadium project (the "Project"); and

b) an existing vanadium concentrate processing operation (the "Existing Operation")  

Balasausqandiq is a very large deposit, with vanadium as the principal product together with several by-products. Owing to the nature of the ore, the capital and operating costs of development are very much lower than for other vanadium projects.  

A reserve on the JORC 2012 basis has been estimated only for the first ore-body (of five) which amounts to 23 million tonnes, not including the small amounts of near-surface oxidised material which is in the Inferred resource category. In the system of reserve estimation used in Kazakhstan the reserves are estimated to be over 70m tonnes in ore-bodies 1 to 5 but this does not include the full depth of ore-bodies 2 to 5.  

There is an existing concentrate processing operation at the site of the Balasausqandiq deposit. The production facilities were originally created from a 15,000 tonnes per year pilot plant which was then adapted to treat concentrates and expanded. Further expansion is being undertaken which is expected to result in annualised production capacity of around 1,500 tonnes of contained vanadium pentoxide plus significant by-product molybdenum.  

The strategy of the Company is to develop both the Project and the Existing Operation in parallel. Although they are located on the same site and use some of the same infrastructure, they are separate operations.

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHSEUFWFEESEFU
Date   Source Headline
26th Apr 20247:00 amRNSQ1 2024 Production Results
15th Feb 20241:00 pmRNSSale of 3rd Tranche of Exempt Offer Bond Programme
1st Feb 20247:00 amRNSFeasibility Study Update & Bond Programme
12th Jan 20247:00 amRNSQ4 2023 Production Results
22nd Dec 20237:00 amRNSTrading Update
30th Nov 20237:00 amRNSTotal Voting Rights
22nd Nov 20237:00 amRNSHolding(s) in Company
21st Nov 202312:17 pmRNSDirector/PDMR Shareholding
14th Nov 20237:00 amRNSIssue of Equity
1st Nov 20235:08 pmRNSResult of AGM
17th Oct 20237:00 amRNSExempt Offer Bond Programme - Second Tranche Sale
10th Oct 202312:53 pmRNSExisting Operation Q3 Production Results
6th Oct 20237:00 amRNSNotice of AGM
19th Sep 20237:00 amRNSExempt Offer Bond Programme - Second Tranche
12th Sep 20237:00 amRNSInvestor Presentation
12th Sep 20237:00 amRNSGrant of Share Options
11th Sep 20237:00 amRNSHalf-year Report
21st Aug 20237:00 amRNSTrading Update
27th Jul 20239:00 amRNSLaunch of Bond Programme /Listing of First Tranche
19th Jul 20237:00 amRNSInvestor Presentation via Investor Meet Company
17th Jul 20237:00 amRNSExisting Operation H1 Production Results
3rd May 20237:00 amRNSInvestor Presentation via Investor Meet Company
2nd May 20232:25 pmRNSDirectors Share Purchase
2nd May 20232:20 pmRNSFull Updated Ore-Body 1 Mineral Resource Estimate
28th Apr 20237:00 amRNS2022 Final Results and Updated Ore-Body 1 MRE
30th Jan 20237:00 amRNSTrading & Operational Update and Grant Funding
20th Dec 20222:05 pmRNSSecond Price Monitoring Extn
20th Dec 20222:00 pmRNSPrice Monitoring Extension
20th Dec 20227:00 amRNSBalasausqandiq Feasibility Study Update
7th Dec 20227:00 amRNSFeasibility Study: Drilling Programme Completes
28th Nov 20224:41 pmRNSSecond Price Monitoring Extn
28th Nov 20224:36 pmRNSPrice Monitoring Extension
28th Nov 20222:05 pmRNSSecond Price Monitoring Extn
28th Nov 20222:00 pmRNSPrice Monitoring Extension
10th Nov 20223:43 pmRNSResult of AGM
13th Oct 20227:00 amRNSNotice of AGM
27th Sep 20226:00 pmRNSHolding(s) in Company
22nd Sep 20227:00 amRNSGrant of Options
15th Sep 20225:15 pmRNSResult of PrimaryBid Offer
15th Sep 202212:20 pmRNSResult of Placing and Subscriptions
15th Sep 20227:02 amRNSPrimaryBid Offer
15th Sep 20227:01 amRNSProposed Placing
15th Sep 20227:00 amRNSInterim Results
1st Jul 20227:38 amRNSBalasausqandiq Feasibility Study Update
1st Jul 20227:00 amRNSBalasausqandiq Feasibility Study Update
29th Jun 20227:00 amRNSGrant of Options
29th Apr 20227:00 amRNSFinal Results
5th Apr 20224:41 pmRNSSecond Price Monitoring Extn
5th Apr 20224:36 pmRNSPrice Monitoring Extension
1st Apr 20227:00 amRNSAppointment of Chief Financial Officer

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.